bf/NASDAQ:MNMD_icon.jpeg

CO:MINDMED

MindMed

  • Stock

USD

Last Close

7.09

22/11 21:00

Market Cap

500.56M

Beta: -

Volume Today

1.02M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Aug '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
average payables
3.10M
-
3.14M
1.44%
3.12M
0.67%
average receivables
book value per share
7.22
-
4.27
40.76%
5.54
29.59%
4.89
11.72%
0.00
99.96%
capex per share
-0.83
-
capex to depreciation
-46.90
-
capex to operating cash flow
1.51
-
capex to revenue
cash per share
0.05
-
4.51
9,448.94%
4.88
8.09%
4.61
5.56%
0.00
99.94%
days of inventory on hand
-0.00
-
days payables outstanding
days sales outstanding
debt to assets
0.00
-
debt to equity
0.00
-
dividend yield
earnings yield
-4.17
-
-0.04
98.99%
-0.16
290.90%
-0.70
324.06%
-0.00
99.90%
enterprise value
249.55K
-
731.88M
293,175.00%
433.17M
40.81%
-74.18M
117.13%
143.22B
193,156.81%
enterprise value over ebitda
-0.54
-
-22.16
3,997.68%
-4.62
79.15%
1.00
121.59%
-1.53K
153,056.79%
ev to operating cash flow
-1.20
-
-31.02
2,486.60%
-9.45
69.52%
1.48
115.65%
-2.23K
150,487.25%
ev to sales
free cash flow per share
-1.37
-
-1.33
3.28%
-1.67
25.89%
-1.62
2.92%
-0.00
99.90%
free cash flow yield
-1.95
-
-0.03
98.51%
-0.08
178.24%
-0.74
813.39%
-0.00
99.94%
graham net net
-0.47
-
4.19
997.99%
4.43
5.55%
3.99
9.91%
0.00
99.97%
graham number
21.85
-
13.59
37.79%
20.58
51.40%
12.98
36.92%
0.01
99.92%
income quality
0.19
-
0.70
272.79%
0.49
29.16%
0.88
79.23%
0.67
23.84%
intangibles to total assets
0
-
0
0.16
Infinity%
0.14
14.98%
0.16
18.21%
interest coverage
-201.40
-
-268.42
33.28%
-44.37
83.47%
interest debt per share
0.01
-
0.01
41.91%
0.05
287.26%
inventory turnover
-792.97K
-
invested capital
0.00
-
market cap
267.48K
-
811.97M
303,458.53%
566.71M
30.21%
67.89M
88.02%
143.32B
211,011.68%
net current asset value
2.74M
-
75.87M
2,670.96%
124.88M
64.60%
126.98M
1.68%
57.47M
54.74%
net debt to ebitda
0.04
-
2.42
6,141.06%
1.42
41.26%
1.91
34.11%
1.06
44.40%
net income per share
-2.94
-
-1.92
34.67%
-3.40
76.87%
-1.53
54.93%
-0.00
99.84%
operating cash flow per share
-0.55
-
-1.33
142.38%
-1.67
25.89%
-1.62
2.92%
-0.00
99.90%
payables turnover
receivables turnover
research and ddevelopement to revenue
return on tangible assets
-0.38
-
-0.42
10.11%
-0.68
62.08%
-0.32
52.38%
-0.92
184.85%
revenue per share
roe
-0.41
-
-0.45
10.29%
-0.61
36.48%
-0.31
48.95%
-1.23
291.25%
roic
-0.17
-
-0.44
155.84%
-0.63
43.46%
-0.37
41.78%
-1.20
228.79%
sales general and administrative to revenue
shareholders equity per share
7.22
-
4.27
40.76%
5.54
29.59%
4.89
11.72%
0.00
99.96%
stock based compensation to revenue
tangible asset value
2.74M
-
75.87M
2,670.96%
124.88M
64.60%
127.31M
1.95%
57.69M
54.69%
tangible book value per share
7.22
-
4.27
40.76%
4.56
6.71%
4.13
9.55%
0.00
99.96%
working capital
2.74M
-
78.51M
2,767.49%
126.81M
61.51%
128.16M
1.07%
71.63M
44.11%

All numbers in USD (except ratios and percentages)